| COVID-19 length of hospital stay: a systematic review and data synthesis EM Rees, ES Nightingale, Y Jafari, NR Waterlow, S Clifford, ... BMC medicine 18, 1-22, 2020 | 732 | 2020 |
| Estimating the burden of antimicrobial resistance: a systematic literature review NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ... Antimicrobial Resistance & Infection Control 7, 1-17, 2018 | 594 | 2018 |
| What settings have been linked to SARS-CoV-2 transmission clusters? QJ Leclerc, NM Fuller, LE Knight, S Funk, GM Knight, ... Wellcome open research 5, 2020 | 450 | 2020 |
| Antimicrobial resistance and COVID-19: Intersections and implications GM Knight, RE Glover, CF McQuaid, ID Olaru, K Gallandat, QJ Leclerc, ... Elife 10, e64139, 2021 | 365 | 2021 |
| The transmission of Mycobacterium tuberculosis in high burden settings TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ... The Lancet infectious diseases 16 (2), 227-238, 2016 | 244 | 2016 |
| Impact and cost-effectiveness of new tuberculosis vaccines in low-and middle-income countries GM Knight, UK Griffiths, T Sumner, YV Laurence, A Gheorghe, A Vassall, ... Proceedings of the National Academy of Sciences 111 (43), 15520-15525, 2014 | 193 | 2014 |
| Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time GM Knight, EL Budd, L Whitney, A Thornley, H Al-Ghusein, T Planche, ... Journal of Antimicrobial Chemotherapy 67 (10), 2514-2522, 2012 | 175 | 2012 |
| Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling GM Knight, CF McQuaid, PJ Dodd, RMGJ Houben The Lancet Infectious Diseases 19 (8), 903-912, 2019 | 174 | 2019 |
| The complex evolution of antibiotic resistance in Mycobacterium tuberculosis JD Fonseca, GM Knight, TD McHugh International journal of infectious diseases 32, 94-100, 2015 | 134 | 2015 |
| Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose JP Garnett, EH Baker, S Naik, JA Lindsay, GM Knight, S Gill, JS Tregoning, ... Thorax 68 (9), 835-845, 2013 | 120 | 2013 |
| The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship JC Emery, TW Russell, Y Liu, J Hellewell, CAB Pearson, GM Knight, ... Elife 9, e58699, 2020 | 118 | 2020 |
| Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines RC Harris, T Sumner, GM Knight, RG White Human vaccines & immunotherapeutics 12 (11), 2813-2832, 2016 | 118 | 2016 |
| Definition of a genetic relatedness cutoff to exclude recent transmission of meticillin-resistant Staphylococcus aureus: a genomic epidemiology analysis F Coll, KE Raven, GM Knight, B Blane, EM Harrison, D Leek, DA Enoch, ... The Lancet Microbe 1 (8), e328-e335, 2020 | 112 | 2020 |
| Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks A Endo, QJ Leclerc, GM Knight, GF Medley, KE Atkins, S Funk, ... Wellcome open research 5, 239, 2021 | 104 | 2021 |
| Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making GM Knight, NJ Dharan, GJ Fox, N Stennis, A Zwerling, R Khurana, ... International journal of infectious diseases 42, 17-23, 2016 | 97 | 2016 |
| The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study NR Naylor, KB Pouwels, R Hope, N Green, KL Henderson, GM Knight, ... PloS one 14 (9), e0221944, 2019 | 84 | 2019 |
| Within-host diversity of MRSA antimicrobial resistances KI Stanczak-Mrozek, A Manne, GM Knight, K Gould, AA Witney, ... Journal of Antimicrobial Chemotherapy 70 (8), 2191-2198, 2015 | 65 | 2015 |
| Mathematical modelling to study the horizontal transfer of antimicrobial resistance genes in bacteria: current state of the field and recommendations QJ Leclerc, JA Lindsay, GM Knight Journal of the royal society interface 16 (157), 20190260, 2019 | 64 | 2019 |
| The distribution of fitness costs of resistance-conferring mutations is a key determinant for the future burden of drug-resistant tuberculosis: a model-based analysis GM Knight, C Colijn, S Shrestha, M Fofana, F Cobelens, RG White, ... Clinical Infectious Diseases 61 (suppl_3), S147-S154, 2015 | 64 | 2015 |
| Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study GM Knight, C Costelloe, SR Deeny, LSP Moore, S Hopkins, AP Johnson, ... BMC medicine 16, 1-11, 2018 | 58 | 2018 |
Richard G WhiteProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical Medicinelshtm.ac.uk의 이메일 확인됨